Alkem Laboratories Live BSE/NSE | Alkem Laboratories Fundamenta data | Alkem Laboratories Balance sheet | Alkem Laboratories Quarterly Results | Alkem Laboratories Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

31,705.65
23.25
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

32,314.29
0.94%
4.82

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

17.31
11.12
9.29

EBITDA CAGR (%)

10 Years
5 Years
3 Years

17.79
11.54
7.87

PAT CAGR (%)

10 Years
5 Years
3 Years

14.32
8.73
21.34

P:E (Median)

8 Years
5 Years
3 Years

-
28.75
30.69

P:BV (Average)

8 Years
5 Years
3 Years

-
4.64
4.61

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
20.06
20.05

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 1,551 1,499 3% 1,688 1,468 15% 1,596 1,536 4% 1,895 1,440 32%
Expenses 1,044 1,233 -15% 1,334 1,230 8% 1,233 1,212 2% 1,410 1,137 24%
EBITDA 507 265 91% 354 238 49% 364 324 12% 485 303 60%
EBIDTM 8% 18% 0% 16% 23% 21% 26% 21%
Other Income 32 13 155% 26 19 36% 27 5 390% 31 24 28%
Interest 12 9 32% 10 1 556% 10 7 34% 10 9 13%
Depreciation 48 40 19% 64 41 56% 43 35 22% 40 33 21%
PBT 479 229 110% 306 215 43% 338 287 18% 465 285 63%
Tax 53 18 195% 35 24 48% -11 46 - 31 46 -33%
PAT 426 211 102% 271 191 42% 349 241 44% 434 238 82%
PATM -2% 14% 3% 13% 22% 16% 23% 17%
EPS 35.63 17.61 102% 22.68 15.95 42% 29.14 20.17 44% 36.29 19.92 82%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 2,003 1,850 8% 2,049 1,854 11% 2,182 1,926 13% 2,264 1,919 18%
Expenses 1,470 1,585 -7% 1,746 1,619 8% 1,729 1,613 7% 1,811 1,555 16%
EBITDA 533 264 102% 303 235 29% 453 314 45% 453 364 24%
EBIDTM 27% 14% 14% 13% 21% 16% 20% 19%
Other Income 44 17 149% 27 28 -1% 28 8 268% 31 25 28%
Interest 17 16 6% 14 7 115% 17 15 11% 18 16 8%
Depreciation 67 56 20% 81 57 42% 59 48 25% 56 46 23%
PBT 493 210 135% 235 199 18% 405 258 57% 410 326 26%
Tax 70 23 206% 44 28 55% 15 53 -72% 29 66 -55%
PAT 423 187 126% 192 170 12% 390 205 90% 381 260 46%
PATM 21% 10% 7% 9% 18% 11% 17% 14%
EPS 35.38 15.66 126% 16.02 14.26 12% 32.61 17.18 90% 31.82 21.77 46%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 6,729 6,677 5,714 5,281 4,548 3,951 3,138 2,708 2,328 1,953 1,652 Net Sales Growth 13% 17% 8% 16% 15% 26% 16% 16% 19% 18% Cost Of Goods Sold 2,077 2,229 1,991 1,739 1,438 1,374 1,162 1,135 908 789 718 Gross Profit 4,652 4,448 3,724 3,542 3,110 2,577 1,976 1,574 1,420 1,164 935 GP Margin 69% 67% 65% 67% 68% 65% 63% 58% 61% 60% 57% Total Expenditure 5,020 5,209 4,668 4,308 3,670 3,231 2,792 2,296 1,872 1,552 1,343 Power & Fuel Cost - 106 99 93 69 52 53 60 53 51 38 % Of Sales - 2% 2% 2% 2% 1% 2% 2% 2% 3% 2% Employee Cost - 1,067 960 862 722 627 561 442 368 276 252 % Of Sales - 16% 17% 16% 16% 16% 18% 16% 16% 14% 15% Manufacturing Exp. - 598 552 593 585 443 335 48 50 38 34 % Of Sales - 9% 10% 11% 13% 11% 11% 2% 2% 2% 2% General & Admin Exp. - 474 433 405 327 262 209 181 145 116 96 % Of Sales - 7% 8% 8% 7% 7% 7% 7% 6% 6% 6% Selling & Distn. Exp. - 687 583 550 457 380 388 319 289 233 177 % Of Sales - 10% 10% 10% 10% 10% 12% 12% 12% 12% 11% Miscellaneous Exp. - 48 51 66 71 93 85 111 59 50 177 % Of Sales - 1% 1% 1% 2% 2% 3% 4% 3% 3% 2% EBITDA 1,709 1,468 1,046 973 878 720 346 413 456 401 310 EBITDA Margin 25% 22% 18% 18% 19% 18% 11% 15% 20% 21% 19% Other Income 116 96 68 101 117 251 182 169 169 135 110 Interest 42 39 28 32 24 59 73 84 79 53 37 Depreciation 195 187 141 108 76 74 60 43 36 28 27 PBT 1,589 1,338 944 934 894 839 395 455 510 454 355 Tax 109 74 144 218 11 139 28 11 14 29 32 Tax Rate 7% 6% 15% 23% 1% 17% 7% 2% 3% 6% 9% PAT 1,480 1,264 800 716 883 700 368 444 496 425 323 PAT before Minority Interest 1,480 1,264 800 716 883 700 368 444 496 425 323 Minority Interest 0 0 0 0 0 0 0 0 0 0 0 PAT Margin 22% 19% 14% 14% 19% 18% 12% 16% 21% 22% 20% PAT Growth 68% 58% 12% -19% 26% 90% -17% -10% 17% 32% EPS 123.74 105.72 66.88 59.85 73.84 58.54 30.74 37.13 41.48 35.58 27.04

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

6,729

6,677

5,714

5,281

4,548

3,951

3,138

2,708

2,328

1,953

1,652

Net Sales Growth

13%

17%

16%

15%

26%

16%

19%

18%

Cost Of Goods Sold

2,077

2,229

1,991

1,739

1,438

1,374

1,162

1,135

908

789

718

Gross Profit

4,652

4,448

3,724

3,542

3,110

2,577

1,976

1,574

1,420

1,164

935

GP Margin

69%

67%

65%

67%

68%

65%

63%

58%

61%

60%

57%

Total Expenditure

5,020

5,209

4,668

4,308

3,670

3,231

2,792

2,296

1,872

1,552

1,343

Power & Fuel Cost

106

% Of Sales

Employee Cost

1,067

960

862

722

627

561

442

368

276

252

% Of Sales

16%

17%

16%

18%

16%

14%

15%

Manufacturing Exp.

598

552

593

585

443

335

% Of Sales

10%

11%

13%

11%

General & Admin Exp.

474

433

405

327

262

209

181

145

116

% Of Sales

Selling & Distn. Exp.

687

583

550

457

380

388

319

289

233

177

% Of Sales

10%

12%

11%

Miscellaneous Exp.

111

177

% Of Sales

EBITDA

1,709

1,468

1,046

973

878

720

346

413

456

401

310

EBITDA Margin

25%

22%

18%

19%

18%

11%

15%

20%

21%

19%

Other Income

116

101

117

251

182

169

135

110

Interest

Depreciation

195

187

141

108

PBT

1,589

1,338

944

934

894

839

395

455

510

454

355

Tax

109

144

218

139

Tax Rate

15%

23%

17%

PAT

1,480

1,264

800

716

883

700

368

444

496

425

323

PAT before Minority Interest

1,480

1,264

800

716

883

700

368

444

496

425

323

Minority Interest

PAT Margin

22%

19%

14%

19%

18%

12%

16%

21%

22%

20%

PAT Growth

68%

58%

12%

-19%

26%

90%

-17%

-10%

17%

32%

EPS

123.74

105.72

66.88

59.85

73.84

58.54

30.74

37.13

41.48

35.58

27.04

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 8,498 8,344 7,357 6,392 5,688 4,925 3,743 3,126 2,495 2,016 1,691 Net Sales Growth 13% 13% 15% 12% 15% 32% 20% 25% 24% 19% Cost Of Goods Sold 7,117 2,959 2,603 1,986 1,808 1,631 1,453 1,168 867 646 597 Gross Profit 1,382 5,385 4,754 4,405 3,880 3,294 2,290 1,958 1,628 1,370 1,094 GP Margin 16% 65% 65% 69% 68% 67% 61% 63% 65% 68% 65% Total Expenditure 6,756 6,871 6,242 5,383 4,689 4,072 3,322 2,716 2,133 1,640 1,404 Power & Fuel Cost - 130 121 113 86 66 53 60 53 51 38 % Of Sales - 2% 2% 2% 2% 1% 1% 2% 2% 3% 2% Employee Cost - 1,505 1,362 1,192 1,004 861 646 532 412 303 267 % Of Sales - 18% 19% 19% 18% 17% 17% 17% 17% 15% 16% Manufacturing Exp. - 765 806 839 692 550 368 306 265 235 196 % Of Sales - 9% 11% 13% 12% 11% 10% 10% 11% 12% 12% General & Admin Exp. - 526 513 470 378 331 238 185 180 139 106 % Of Sales - 6% 7% 7% 7% 7% 6% 6% 7% 7% 6% Selling & Distn. Exp. - 854 726 675 596 504 435 367 295 226 167 % Of Sales - 10% 10% 11% 10% 10% 12% 12% 12% 11% 10% Miscellaneous Exp. - 131 111 108 124 128 128 98 60 40 167 % Of Sales - 2% 2% 2% 2% 3% 3% 3% 2% 2% 2% EBITDA 1,742 1,473 1,115 1,009 999 853 422 410 362 375 287 EBITDA Margin 20% 18% 15% 16% 18% 17% 11% 13% 15% 19% 17% Other Income 130 104 88 115 112 240 181 165 167 145 113 Interest 66 65 55 55 45 71 81 93 88 58 41 Depreciation 264 253 193 143 101 93 71 52 40 29 27 PBT 1,543 1,260 955 926 965 928 451 430 402 433 331 Tax 157 110 181 288 60 176 59 -5 18 28 36 Tax Rate 10% 9% 19% 31% 6% 19% 13% -1% 4% 6% 11% PAT 1,385 1,127 761 631 892 742 392 435 384 407 296 PAT before Minority Interest 1,366 1,149 774 638 905 752 392 435 384 406 296 Minority Interest -19 -22 -13 -7 -13 -11 0 0 0 1 0 PAT Margin 16% 14% 10% 10% 16% 15% 10% 14% 15% 20% 17% PAT Growth 68% 48% 21% -29% 20% 89% -10% 13% -6% 38% EPS 115.82 94.24 63.59 52.75 74.58 62.01 32.74 36.40 32.09 33.99 24.71

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

8,498

8,344

7,357

6,392

5,688

4,925

3,743

3,126

2,495

2,016

1,691

Net Sales Growth

13%

15%

12%

15%

32%

20%

25%

24%

19%

Cost Of Goods Sold

7,117

2,959

2,603

1,986

1,808

1,631

1,453

1,168

867

646

597

Gross Profit

1,382

5,385

4,754

4,405

3,880

3,294

2,290

1,958

1,628

1,370

1,094

GP Margin

16%

65%

69%

68%

67%

61%

63%

65%

68%

65%

Total Expenditure

6,756

6,871

6,242

5,383

4,689

4,072

3,322

2,716

2,133

1,640

1,404

Power & Fuel Cost

130

121

113

% Of Sales

Employee Cost

1,505

1,362

1,192

1,004

861

646

532

412

303

267

% Of Sales

18%

19%

18%

17%

15%

16%

Manufacturing Exp.

765

806

839

692

550

368

306

265

235

196

% Of Sales

11%

13%

12%

11%

10%

11%

12%

General & Admin Exp.

526

513

470

378

331

238

185

180

139

106

% Of Sales

Selling & Distn. Exp.

854

726

675

596

504

435

367

295

226

167

% Of Sales

10%

11%

10%

12%

11%

10%

Miscellaneous Exp.

131

111

108

124

128

167

% Of Sales

EBITDA

1,742

1,473

1,115

1,009

999

853

422

410

362

375

287

EBITDA Margin

20%

18%

15%

16%

18%

17%

11%

13%

15%

19%

17%

Other Income

130

104

115

112

240

181

165

167

145

113

Interest

Depreciation

264

253

193

143

101

PBT

1,543

1,260

955

926

965

928

451

430

402

433

331

Tax

157

110

181

288

176

-5

Tax Rate

10%

19%

31%

19%

13%

-1%

11%

PAT

1,385

1,127

761

631

892

742

392

435

384

407

296

PAT before Minority Interest

1,366

1,149

774

638

905

752

392

435

384

406

296

Minority Interest

-19

-22

-13

-7

-13

-11

PAT Margin

16%

14%

10%

16%

15%

10%

14%

15%

20%

17%

PAT Growth

68%

48%

21%

-29%

20%

89%

-10%

13%

-6%

38%

EPS

115.82

94.24

63.59

52.75

74.58

62.01

32.74

36.40

32.09

33.99

24.71

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 6,280 5,465 4,885 4,393 3,600 3,105 2,790 2,374 1,906 1,508 Share Capital 24 24 24 24 24 24 12 12 12 12 Total Reserves 6,257 5,441 4,861 4,369 3,576 3,081 2,778 2,362 1,894 1,496 Non-Current Liabilities -574 -452 -436 -499 -341 153 143 174 198 132 Secured Loans 55 6 6 0 0 28 54 92 127 67 Unsecured Loans 0 0 0 0 0 0 0 0 0 0 Long Term Provisions 182 169 126 81 66 57 28 31 34 34 Current Liabilities 2,578 1,643 1,787 1,413 1,154 1,603 1,300 1,501 1,079 950 Trade Payables 812 754 819 685 466 347 276 258 262 167 Other Current Liabilities 396 287 324 256 248 144 123 116 97 78 Short Term Borrowings 1,203 497 541 368 351 1,046 854 1,103 676 665 Short Term Provisions 167 104 102 104 90 67 47 24 44 40 Total Liabilities 8,284 6,656 6,236 5,307 4,413 4,861 4,232 4,048 3,182 2,589 Net Block 1,837 1,606 1,471 1,126 875 870 839 760 580 465 Gross Block 2,352 1,973 1,714 1,263 945 1,156 1,069 951 738 597 Accumulated Depreciation 515 367 243 137 70 286 231 191 158 132 Non Current Assets 4,065 3,575 3,204 3,039 2,334 3,084 2,023 1,354 1,005 638 Capital Work in Progress 314 382 299 218 147 96 71 86 85 19 Non Current Investment 1,795 1,476 1,203 1,226 885 1,011 610 103 50 11 Long Term Loans & Adv. 115 94 206 179 238 646 504 405 290 143 Other Non Current Assets 5 17 25 290 190 460 0 0 0 0 Current Assets 4,220 3,081 3,032 2,268 2,079 1,777 2,209 2,694 2,178 1,951 Current Investments 162 219 341 292 273 60 331 476 322 42 Inventories 1,093 991 1,024 859 590 548 505 443 297 228 Sundry Debtors 1,555 967 875 633 480 375 297 302 258 163 Cash & Bank 766 398 278 199 524 633 891 1,257 1,131 1,424 Other Current Assets 645 164 162 127 212 161 185 216 170 94 Short Term Loans & Adv. 388 342 351 158 125 108 124 111 74 10 Net Current Assets 1,641 1,438 1,245 855 925 174 909 1,193 1,099 1,001 Total Assets 8,284 6,656 6,236 5,307 4,413 4,861 4,232 4,048 3,182 2,589

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

6,280

5,465

4,885

4,393

3,600

3,105

2,790

2,374

1,906

1,508

Share Capital

Total Reserves

6,257

5,441

4,861

4,369

3,576

3,081

2,778

2,362

1,894

1,496

Non-Current Liabilities

-574

-452

-436

-499

-341

153

143

174

198

132

Secured Loans

127

Unsecured Loans

Long Term Provisions

182

169

126

Current Liabilities

2,578

1,643

1,787

1,413

1,154

1,603

1,300

1,501

1,079

950

Trade Payables

812

754

819

685

466

347

276

258

262

167

Other Current Liabilities

396

287

324

256

248

144

123

116

Short Term Borrowings

1,203

497

541

368

351

1,046

854

1,103

676

665

Short Term Provisions

167

104

102

104

Total Liabilities

8,284

6,656

6,236

5,307

4,413

4,861

4,232

4,048

3,182

2,589

Net Block

1,837

1,606

1,471

1,126

875

870

839

760

580

465

Gross Block

2,352

1,973

1,714

1,263

945

1,156

1,069

951

738

597

Accumulated Depreciation

515

367

243

137

286

231

191

158

132

Non Current Assets

4,065

3,575

3,204

3,039

2,334

3,084

2,023

1,354

1,005

638

Capital Work in Progress

314

382

299

218

147

Non Current Investment

1,795

1,476

1,203

1,226

885

1,011

610

103

Long Term Loans & Adv.

115

206

179

238

646

504

405

290

143

Other Non Current Assets

290

190

460

Current Assets

4,220

3,081

3,032

2,268

2,079

1,777

2,209

2,694

2,178

1,951

Current Investments

162

219

341

292

273

331

476

322

Inventories

1,093

991

1,024

859

590

548

505

443

297

228

Sundry Debtors

1,555

967

875

633

480

375

297

302

258

163

Cash & Bank

766

398

278

199

524

633

891

1,257

1,131

1,424

Other Current Assets

645

164

162

127

212

161

185

216

170

Short Term Loans & Adv.

388

342

351

158

125

108

124

111

Net Current Assets

1,641

1,438

1,245

855

925

174

909

1,193

1,099

1,001

Total Assets

8,284

6,656

6,236

5,307

4,413

4,861

4,232

4,048

3,182

2,589

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 6,161 5,439 4,864 4,468 3,692 3,003 2,585 2,177 1,820 1,434 Share Capital 24 24 24 24 24 24 12 12 12 12 Total Reserves 6,135 5,414 4,839 4,443 3,668 2,979 2,573 2,165 1,808 1,422 Non-Current Liabilities -542 -262 -359 -401 -306 197 324 362 525 434 Secured Loans 149 220 122 175 112 33 232 256 309 246 Unsecured Loans 10 12 9 7 11 0 0 0 0 0 Long Term Provisions 222 201 150 102 83 67 42 44 180 162 Current Liabilities 3,243 2,190 2,383 1,690 1,538 2,006 1,403 1,732 1,121 982 Trade Payables 954 962 961 741 580 466 306 288 276 168 Other Current Liabilities 555 428 520 339 366 327 201 188 111 87 Short Term Borrowings 1,504 671 761 472 464 1,129 845 1,210 670 663 Short Term Provisions 230 129 141 137 127 84 50 46 63 64 Total Liabilities 9,011 7,501 7,010 5,872 5,018 5,291 4,311 4,271 3,466 2,852 Net Block 2,908 2,530 2,284 1,797 1,450 1,374 1,170 1,072 919 693 Gross Block 3,607 3,026 2,604 1,977 1,539 1,745 1,170 1,072 919 693 Accumulated Depreciation 699 496 320 180 89 371 0 0 0 0 Non Current Assets 3,515 3,284 2,997 2,955 2,250 2,953 2,709 2,115 2,153 1,313 Capital Work in Progress 363 493 381 299 172 111 0 0 0 0 Non Current Investment 92 96 98 259 234 420 338 410 299 6 Long Term Loans & Adv. 106 119 141 193 142 542 418 339 259 154 Other Non Current Assets 47 47 92 406 251 506 783 293 677 460 Current Assets 5,496 4,216 4,013 2,917 2,769 2,338 1,602 2,156 1,312 1,539 Current Investments 170 228 346 294 274 61 250 67 24 48 Inventories 1,819 1,500 1,442 1,206 909 784 620 554 385 251 Sundry Debtors 1,649 1,248 1,080 714 568 527 367 318 247 171 Cash & Bank 1,092 662 577 399 781 791 206 995 514 990 Other Current Assets 766 173 177 133 237 175 159 221 143 79 Short Term Loans & Adv. 482 405 391 171 141 115 110 115 80 40 Net Current Assets 2,253 2,026 1,630 1,227 1,231 332 200 424 192 0 Total Assets 9,011 7,501 7,010 5,872 5,018 5,291 4,311 4,271 3,466 2,852

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

6,161

5,439

4,864

4,468

3,692

3,003

2,585

2,177

1,820

1,434

Share Capital

Total Reserves

6,135

5,414

4,839

4,443

3,668

2,979

2,573

2,165

1,808

1,422

Non-Current Liabilities

-542

-262

-359

-401

-306

197

324

362

525

434

Secured Loans

149

220

122

175

112

232

256

309

246

Unsecured Loans

Long Term Provisions

222

201

150

102

180

162

Current Liabilities

3,243

2,190

2,383

1,690

1,538

2,006

1,403

1,732

1,121

982

Trade Payables

954

962

961

741

580

466

306

288

276

168

Other Current Liabilities

555

428

520

339

366

327

201

188

111

Short Term Borrowings

1,504

671

761

472

464

1,129

845

1,210

670

663

Short Term Provisions

230

129

141

137

127

Total Liabilities

9,011

7,501

7,010

5,872

5,018

5,291

4,311

4,271

3,466

2,852

Net Block

2,908

2,530

2,284

1,797

1,450

1,374

1,170

1,072

919

693

Gross Block

3,607

3,026

2,604

1,977

1,539

1,745

1,170

1,072

919

693

Accumulated Depreciation

699

496

320

180

371

Non Current Assets

3,515

3,284

2,997

2,955

2,250

2,953

2,709

2,115

2,153

1,313

Capital Work in Progress

363

493

381

299

172

111

Non Current Investment

259

234

420

338

410

299

Long Term Loans & Adv.

106

119

141

193

142

542

418

339

259

154

Other Non Current Assets

406

251

506

783

293

677

460

Current Assets

5,496

4,216

4,013

2,917

2,769

2,338

1,602

2,156

1,312

1,539

Current Investments

170

228

346

294

274

250

Inventories

1,819

1,500

1,442

1,206

909

784

620

554

385

251

Sundry Debtors

1,649

1,248

1,080

714

568

527

367

318

247

171

Cash & Bank

1,092

662

577

399

781

791

206

995

514

990

Other Current Assets

766

173

177

133

237

175

159

221

143

Short Term Loans & Adv.

482

405

391

171

141

115

110

115

Net Current Assets

2,253

2,026

1,630

1,227

1,231

332

200

424

192

Total Assets

9,011

7,501

7,010

5,872

5,018

5,291

4,311

4,271

3,466

2,852

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 682 743 318 499 630 242 106 556 118 838 PBT 1,338 944 934 894 839 395 455 510 454 355 Adjustment 141 130 77 -4 -65 -32 6 -44 -46 -28 Changes in Working Capital -564 -127 -512 -187 3 -16 -247 197 -194 577 Cash after chg. in Working capital 916 947 500 704 777 347 214 662 215 905 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -234 -204 -181 -205 -147 -106 -109 -107 -97 -67 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -995 -311 -273 -362 311 -260 37 -40 -723 -45 Net Fixed Assets -311 -342 -531 -390 161 -112 -103 -214 -207 -110 Net Investments -260 -151 -27 -360 -87 -130 -361 -207 -319 -34 Others -424 182 285 388 237 -18 501 381 -197 99 Cash from Financing Activity 173 -276 -60 -125 -958 26 -154 -166 -14 -31 Net Cash Inflow / Outflow -141 156 -15 13 -18 8 -12 350 -619 762 Opening Cash & Equivalents 161 5 20 7 25 17 29 80 699 662 Closing Cash & Equivalent 21 161 5 20 7 25 17 430 80 1,424

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

682

743

318

499

630

242

106

556

118

838

PBT

1,338

944

934

894

839

395

455

510

454

355

Adjustment

141

130

-4

-65

-32

-44

-46

-28

Changes in Working Capital

-564

-127

-512

-187

-16

-247

197

-194

577

Cash after chg. in Working capital

916

947

500

704

777

347

214

662

215

905

Interest Paid

Tax Paid

-234

-204

-181

-205

-147

-106

-109

-107

-97

-67

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-995

-311

-273

-362

311

-260

-40

-723

-45

Net Fixed Assets

-311

-342

-531

-390

161

-112

-103

-214

-207

-110

Net Investments

-260

-151

-27

-360

-87

-130

-361

-207

-319

-34

Others

-424

182

285

388

237

-18

501

381

-197

Cash from Financing Activity

173

-276

-60

-125

-958

-154

-166

-14

-31

Net Cash Inflow / Outflow

-141

156

-15

-18

-12

350

-619

762

Opening Cash & Equivalents

161

699

662

Closing Cash & Equivalent

161

430

1,424

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity 585 777 266 471 726 328 290 78 159 148 PBT 1,260 955 926 965 928 514 430 402 433 331 Adjustment 256 216 116 33 -14 16 7 -31 -33 -18 Changes in Working Capital -647 -143 -573 -263 10 -96 -36 -183 -145 -99 Cash after chg. in Working capital 868 1,029 469 735 924 434 401 188 256 215 Interest Paid 0 0 0 0 0 0 0 0 0 0 Tax Paid -283 -251 -203 -264 -198 -106 -111 -110 -97 -67 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 0 0 Cash From Investing Activity -741 -314 -357 -286 202 -237 350 -404 -248 -823 Net Fixed Assets -311 -342 -531 -390 161 -112 -103 -214 -207 Net Investments -260 -151 -27 -360 -87 -130 -361 -207 -319 Others -170 179 201 464 129 5 815 17 278 Cash from Financing Activity 79 -379 85 -138 -927 -52 -600 356 -11 779 Net Cash Inflow / Outflow -77 84 -7 47 1 39 41 30 -100 104 Opening Cash & Equivalents 249 167 167 127 124 101 57 26 124 20 Closing Cash & Equivalent 176 249 167 167 127 140 101 57 26 124

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

585

777

266

471

726

328

290

159

148

PBT

1,260

955

926

965

928

514

430

402

433

331

Adjustment

256

216

116

-14

-31

-33

-18

Changes in Working Capital

-647

-143

-573

-263

-96

-36

-183

-145

-99

Cash after chg. in Working capital

868

1,029

469

735

924

434

401

188

256

215

Interest Paid

Tax Paid

-283

-251

-203

-264

-198

-106

-111

-110

-97

-67

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-741

-314

-357

-286

202

-237

350

-404

-248

-823

Net Fixed Assets

-311

-342

-531

-390

161

-112

-103

-214

-207

Net Investments

-260

-151

-27

-360

-87

-130

-361

-207

-319

Others

-170

179

201

464

129

815

278

Cash from Financing Activity

-379

-138

-927

-52

-600

356

-11

779

Net Cash Inflow / Outflow

-77

-7

-100

104

Opening Cash & Equivalents

249

167

127

124

101

124

Closing Cash & Equivalent

176

249

167

127

140

101

124

Financial Ratios

Consolidated /

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 525 457 409 367 301 260 233 199 159 126 ROA 17% 12% 12% 18% 15% 8% 11% 14% 15% 16% ROE 22% 15% 15% 22% 21% 12% 17% 23% 25% 24% ROCE 20% 17% 19% 21% 22% 12% 15% 19% 20% 22% Fixed Asset Turnover 3.23 3.23 3.71 4.23 3.76 2.92 2.79 2.85 3.01 3.08 Receivable days 66 56 50 44 40 38 39 42 38 30 Inventory Days 54 62 62 57 53 59 61 56 48 44 Payable days 58 67 67 59 51 44 46 52 53 24 Cash Conversion Cycle 62 51 45 41 41 53 54 47 33 50 Total Debt/Equity 0.20 0.09 0.11 0.08 0.11 0.36 0.34 0.52 0.44 0.49 Interest Cover 36 34 30 39 15 6 6 7 10 10

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

525

457

409

367

301

260

233

199

159

126

ROA

17%

12%

18%

15%

11%

14%

15%

16%

ROE

22%

15%

22%

21%

12%

17%

23%

25%

24%

ROCE

20%

17%

19%

21%

22%

12%

15%

19%

20%

22%

Fixed Asset Turnover

3.23

3.71

4.23

3.76

2.92

2.79

2.85

3.01

3.08

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

0.20

0.09

0.11

0.08

0.11

0.36

0.34

0.52

0.44

0.49

Interest Cover

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 515 455 407 374 309 251 216 182 152 0 ROA 14% 11% 10% 17% 15% 8% 10% 10% 13% 10% ROE 20% 15% 14% 22% 22% 14% 18% 19% 25% 21% ROCE 19% 16% 18% 21% 23% 13% 14% 15% 19% 16% Fixed Asset Turnover 3.74 3.80 3.75 3.33 3.07 2.65 2.89 2.59 2.57 2.49 Receivable days 43 40 38 40 40 42 39 40 37 36 Inventory Days 49 50 56 66 61 66 66 67 56 53 Payable days 52 60 61 52 50 46 43 49 50 47 Cash Conversion Cycle 39 30 33 54 51 63 62 57 43 42 Total Debt/Equity 0.28 0.17 0.21 0.15 0.18 0.43 0.44 0.71 0.55 0.00 Interest Cover 20 18 18 22 14 7 6 6 8 9

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

515

455

407

374

309

251

216

182

152

ROA

14%

11%

10%

17%

15%

10%

13%

10%

ROE

20%

15%

14%

22%

14%

18%

19%

25%

21%

ROCE

19%

16%

18%

21%

23%

13%

14%

15%

19%

16%

Fixed Asset Turnover

3.74

3.80

3.75

3.33

3.07

2.65

2.89

2.59

2.57

2.49

Receivable days

Inventory Days

Payable days

Cash Conversion Cycle

Total Debt/Equity

0.28

0.17

0.21

0.15

0.18

0.43

0.44

0.71

0.55

0.00

Interest Cover

Alkem Laboratories Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 539523 | NSE: ALKEM

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update

Alkem Laboratories Ltd.

Pharmaceuticals & Drugs - Domestic

BSE: 539523 | NSE: ALKEM

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Annual Reports:

News Update